US Stock MarketDetailed Quotes
XAIR Beyond Air
- 0.515
- -0.051-9.01%
Close Nov 29 13:00 ET
- 0.513
- -0.002-0.33%
Post 17:01 ET
37.18MMarket Cap-365P/E (TTM)
0.578High0.500Low809.94KVolume0.578Open0.566Pre Close420.54KTurnover1.66%Turnover RatioLossP/E (Static)72.19MShares2.36052wk High1.32P/B25.08MFloat Cap0.29652wk Low--Dividend TTM48.70MShs Float16.410Historical High--Div YieldTTM13.78%Amplitude0.296Historical Low0.519Avg Price1Lot Size
Beyond Air Stock Forum
Sign in to post a comment
$Beyond Air (XAIR.US)$ Revenues increased 17% compared to the previous quarter ended June 30, 2024
Strengthened balance sheet is expected to provide sufficient cash runway through June 2026
Completed a $20.6 million private placement offering with multiple healthcare-focused institutional funds and Company insiders
Retired $17.5 million in debt from Avenue Capital and entered into a $11.5 million loan agreement with an insider-led investor group
Conference call scheduled for 4:30 p.m. ET today...
Strengthened balance sheet is expected to provide sufficient cash runway through June 2026
Completed a $20.6 million private placement offering with multiple healthcare-focused institutional funds and Company insiders
Retired $17.5 million in debt from Avenue Capital and entered into a $11.5 million loan agreement with an insider-led investor group
Conference call scheduled for 4:30 p.m. ET today...
$Beyond Air (XAIR.US)$
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer presented promising preclinical data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy at SITC 2024. The study showed that LV UNO combined with anti-rPD-L1 doubled tumor growth inhibition and improved survival in MAT B III tumor-bearing rats compared t...
Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer presented promising preclinical data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy at SITC 2024. The study showed that LV UNO combined with anti-rPD-L1 doubled tumor growth inhibition and improved survival in MAT B III tumor-bearing rats compared t...
$Beyond Air (XAIR.US)$ I am holding this one, it looks like good earnings coming up 11/11 🚀🚀🚀🚀🚀
$Beyond Air (XAIR.US)$
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer, , a clinical stage biotechnology company, has been selected to present two poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024. The event is scheduled for November 6-10 at the George R. Brown Convention Center in Houston, Texas. The ...
Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Beyond Cancer, , a clinical stage biotechnology company, has been selected to present two poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024. The event is scheduled for November 6-10 at the George R. Brown Convention Center in Houston, Texas. The ...
1
$Intellinetics (INLX.US)$ $Lm Funding America (LMFA.US)$ $Beyond Air (XAIR.US)$ $Jianzhi Education (JZ.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Martin Midstream (MMLP.US)$ $Edesa Biotech (EDSA.US)$ $AIM ImmunoTech (AIM.US)$ $Smart Sand (SND.US)$ $SPI Energy (SPI.US)$ $Renovaro (RENB.US)$ $Phoenix Motor (PEV.US)$
1
$Beyond Air (XAIR.US)$ com boy 🐎🐎🐎
1
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
BadPaint OP : Easy money